{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:13:35Z","timestamp":1791947615624,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-47\/2023-01\/200113"],"award-info":[{"award-number":["451-03-47\/2023-01\/200113"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s11095-024-03675-5","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T22:01:41Z","timestamp":1707516101000},"page":"493-500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Monte Carlo Optimization Method Based QSAR Modeling of Placental Barrier Permeability"],"prefix":"10.1007","volume":"41","author":[{"given":"Predrag","family":"Vukomanovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Stefanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena Milo\u0161evi\u0107","family":"Stevanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Petri\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Trenki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazar","family":"Andrejevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Lazarevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danka","family":"Sokolovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9291-6654","authenticated-orcid":false,"given":"Aleksandar M.","family":"Veselinovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,9]]},"reference":[{"key":"3675_CR1","doi-asserted-by":"publisher","first-page":"20190031","DOI":"10.1098\/rsfs.2019.0031","volume":"9","author":"RL Pemathilaka","year":"2019","unstructured":"Pemathilaka RL, Reynolds DE, Hashemi NN. Drug transport across the human placenta: review of placenta-on-a-chip and previous approaches. Interface Focus. 2019;9:20190031. https:\/\/doi.org\/10.1098\/rsfs.2019.0031.","journal-title":"Interface Focus"},{"key":"3675_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1517\/17425255.2.1.51","volume":"2","author":"D Evseenko","year":"2006","unstructured":"Evseenko D, Paxton JW, Keelan JA. Active transport across the human placenta: impact on drug efficacy and toxicity. Expert Opin Drug Metab Toxicol. 2006;2:51\u201369. https:\/\/doi.org\/10.1517\/17425255.2.1.51.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3675_CR3","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2174\/138161206776389813","volume":"12","author":"TF Collins","year":"2006","unstructured":"Collins TF. History and evolution of reproductive and developmental toxicology guidelines. Curr Pharm Des. 2006;12:1449\u201365. https:\/\/doi.org\/10.2174\/138161206776389813.","journal-title":"Curr Pharm Des"},{"key":"3675_CR4","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.2174\/138161207782110499","volume":"13","author":"EV Younglai","year":"2007","unstructured":"Younglai EV, Wu YJ, Foster WG. Reproductive toxicology of environmental toxicants: emerging issues and concerns. Curr Pharm Des. 2007;13:3005\u201319. https:\/\/doi.org\/10.2174\/138161207782110499.","journal-title":"Curr Pharm Des"},{"key":"3675_CR5","doi-asserted-by":"publisher","first-page":"13149","DOI":"10.3390\/ijms222313149","volume":"22","author":"M Yamashita","year":"2021","unstructured":"Yamashita M, Markert UR. Overview of Drug Transporters in Human Placenta. Int J Mol Sci. 2021;22:13149. https:\/\/doi.org\/10.3390\/ijms222313149.","journal-title":"Int J Mol Sci"},{"key":"3675_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/clpt.2011.66","volume":"90","author":"JR Hutson","year":"2011","unstructured":"Hutson JR, Garcia-Bournissen F, Davis A, Koren G. The human placental perfusion model: a systematic review and development of a model to predict in vivo transfer of therapeutic drugs. Clin Pharmacol Ther. 2011;90:67\u201376. https:\/\/doi.org\/10.1038\/clpt.2011.66.","journal-title":"Clin Pharmacol Ther"},{"key":"3675_CR7","doi-asserted-by":"publisher","first-page":"8823","DOI":"10.1080\/14767058.2021.2005565","volume":"35","author":"P Calis","year":"2022","unstructured":"Calis P, Vojtech L, Hladik F, Gravett MG. A review of ex vivo placental perfusion models: an underutilized but promising method to study maternal-fetal interactions. J Matern Fetal Neonatal Med. 2022;35:8823\u201335. https:\/\/doi.org\/10.1080\/14767058.2021.2005565.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"3675_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1515\/mr-2022-0025","volume":"2","author":"Q Mao","year":"2022","unstructured":"Mao Q, Chen X. An update on placental drug transport and its relevance to fetal drug exposure. Med Rev (Berl). 2022;2:501\u201311. https:\/\/doi.org\/10.1515\/mr-2022-0025.","journal-title":"Med Rev (Berl)"},{"key":"3675_CR9","doi-asserted-by":"publisher","first-page":"804","DOI":"10.2174\/138920111795470930","volume":"12","author":"C Giaginis","year":"2011","unstructured":"Giaginis C, Tsantili-Kakoulidou A, Theocharis S. Assessing drug transport across the human placental barrier: from in vivo and in vitro measurements to the ex vivo perfusion method and in silico techniques. Curr Pharm Biotechnol. 2011;12:804\u201313. https:\/\/doi.org\/10.2174\/138920111795470930.","journal-title":"Curr Pharm Biotechnol"},{"issue":"2","key":"3675_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.mrgentox.2006.02.014","volume":"608","author":"K V\u00e4h\u00e4kangas","year":"2006","unstructured":"V\u00e4h\u00e4kangas K, Myllynen P. Experimental methods to study human transplacental exposure to genotoxic agents. Mutat Res. 2006;608(2):129\u201335. https:\/\/doi.org\/10.1016\/j.mrgentox.2006.02.014.","journal-title":"Mutat Res"},{"key":"3675_CR11","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1517\/17425255.2012.699041","volume":"8","author":"C Giaginis","year":"2012","unstructured":"Giaginis C, Theocharis S, Tsantili-Kakoulidou A. Current toxicological aspects on drug and chemical transport and metabolism across the human placental barrier. Expert Opin Drug Metab Toxicol. 2012;8:1263\u201375. https:\/\/doi.org\/10.1517\/17425255.2012.699041.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3675_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.tiv.2012.08.027","volume":"27","author":"P Myllynen","year":"2013","unstructured":"Myllynen P, V\u00e4h\u00e4kangas K. Placental transfer and metabolism: an overview of the experimental models utilizing human placental tissue. Toxicol In Vitro. 2013;27:507\u201312. https:\/\/doi.org\/10.1016\/j.tiv.2012.08.027.","journal-title":"Toxicol In Vitro"},{"key":"3675_CR13","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1021\/jm4004285","volume":"57","author":"A Cherkasov","year":"2014","unstructured":"Cherkasov A, et al. QSAR modeling: Where have you been? Where are you going to? J Med Chem. 2014;57:4977\u20135010. https:\/\/doi.org\/10.1021\/jm4004285.","journal-title":"J Med Chem"},{"key":"3675_CR14","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.3390\/ijms10051978","volume":"10","author":"P Liu","year":"2009","unstructured":"Liu P, Long W. Current mathematical methods used in QSAR\/QSPR studies. Int J Mol Sci. 2009;10:1978\u201398. https:\/\/doi.org\/10.3390\/ijms10051978.","journal-title":"Int J Mol Sci"},{"key":"3675_CR15","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.2174\/156802608786786552","volume":"8","author":"M P\u00e9rez Gonz\u00e1lez","year":"2008","unstructured":"P\u00e9rez Gonz\u00e1lez M, Ter\u00e1n C, Sa\u00edaz-Urra L, Teijeira M. Variables selection methods in QSAR: An overview. Curr Top Med Chem. 2008;8:1606\u201327. https:\/\/doi.org\/10.2174\/156802608786786552.","journal-title":"Curr Top Med Chem"},{"key":"3675_CR16","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.2174\/1568026615666150506151533","volume":"15","author":"AM Veselinovi\u0107","year":"2015","unstructured":"Veselinovi\u0107 AM, Veselinovi\u0107 JB, \u017divkovi\u0107 JV, Nikoli\u0107 GM. Application of SMILES notation based optimal descriptors in drug discovery and design. Curr Top Med Chem. 2015;15:1768\u20132177. https:\/\/doi.org\/10.2174\/1568026615666150506151533.","journal-title":"Curr Top Med Chem"},{"key":"3675_CR17","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.2174\/1389557520666200212111428","volume":"20","author":"M Zivkovic","year":"2020","unstructured":"Zivkovic M, Zlatanovic M, Zlatanovic N, Golubovi\u0107 M, Veselinovi\u0107 AM. The application of the combination of Monte Carlo optimization method based QSAR modeling and molecular docking in drug design and development. Mini-Rev Med Chem. 2020;20:1389\u2013402. https:\/\/doi.org\/10.2174\/1389557520666200212111428.","journal-title":"Mini-Rev Med Chem"},{"key":"3675_CR18","doi-asserted-by":"publisher","first-page":"382","DOI":"10.2174\/1389557517666170927154931","volume":"18","author":"AP Toropova","year":"2018","unstructured":"Toropova AP, Toropov AA. CORAL: Monte Carlo method to predict endpoints for medical chemistry. Mini Rev Med Chem. 2018;18:382\u201391. https:\/\/doi.org\/10.2174\/1389557517666170927154931.","journal-title":"Mini Rev Med Chem"},{"key":"3675_CR19","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.coph.2013.06.001","volume":"13","author":"A Roncaglioni","year":"2013","unstructured":"Roncaglioni A, Toropov AA, Toropova AP, Benfenati E. In silico methods to predict drug toxicity. Curr Opin Pharmacol. 2013;13:802\u20136. https:\/\/doi.org\/10.1016\/j.coph.2013.06.001.","journal-title":"Curr Opin Pharmacol"},{"key":"3675_CR20","doi-asserted-by":"publisher","first-page":"8270","DOI":"10.3390\/molecules20058270","volume":"20","author":"YH Zhang","year":"2015","unstructured":"Zhang YH, Xia ZN, Yan L, Liu SS. Prediction of placental barrier permeability: a model based on partial least squares variable selection procedure. Molecules. 2015;20:8270\u201386. https:\/\/doi.org\/10.3390\/molecules20058270.","journal-title":"Molecules"},{"key":"3675_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.chemolab.2011.08.007","volume":"109","author":"PK Ojha","year":"2011","unstructured":"Ojha PK, Roy K. Comparative QSARs for antimalarial endochins: importance of descriptor-thinning and noise reduction prior to feature selection. Chemometr Intell Lab. 2011;109:146\u201361. https:\/\/doi.org\/10.1016\/j.chemolab.2011.08.007.","journal-title":"Chemometr Intell Lab"},{"key":"3675_CR22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/i4050272","volume":"4","author":"AA Toropov","year":"2003","unstructured":"Toropov AA, Duchowicz P, Castro EA. Structure-toxicity relationships for aliphatic compounds based on correlation weighting of local graph invariants. Int J Mol Sci. 2003;4:272\u201383. https:\/\/doi.org\/10.3390\/i4050272.","journal-title":"Int J Mol Sci"},{"key":"3675_CR23","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1093-3263(01)00123-1","volume":"20","author":"A Golbraikh","year":"2002","unstructured":"Golbraikh A, Tropsha A. Beware of q2! J Mol Graph Model. 2002;20:269\u201376.","journal-title":"J Mol Graph Model"},{"key":"3675_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.chemolab.2007.07.004","volume":"90","author":"PP Roy","year":"2008","unstructured":"Roy PP, Leonard JT, Roy K. Exploring the impact of size of training sets for the development of predictive QSAR models. Chemometr Intell Lab. 2008;90:31\u201342.","journal-title":"Chemometr Intell Lab"},{"key":"3675_CR25","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.chemolab.2011.03.011","volume":"107","author":"PK Ojha","year":"2011","unstructured":"Ojha PK, Mitra I, Das RN, Roy K. Further exploring rm2 metrics for validation of QSPR models. Chemometr Intell Lab. 2011;107:194\u2013205.","journal-title":"Chemometr Intell Lab"},{"key":"3675_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.chemolab.2016.01.008","volume":"152","author":"K Roy","year":"2016","unstructured":"Roy K, Das RN, Ambure P, Aher RB. Be aware of error measures. Further studies on validation of predictive QSAR models. Chemometr Intell Lab. 2016;152:18\u201333.","journal-title":"Chemometr Intell Lab."},{"key":"3675_CR27","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.scitotenv.2017.01.198","volume":"586","author":"AP Toropova","year":"2017","unstructured":"Toropova AP, Toropov AA. The index of ideality of correlation: A criterion of predictability of QSAR models for skin permeability? Sci Total Environ. 2017;586:466\u201372.","journal-title":"Sci Total Environ"},{"key":"3675_CR28","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1080\/1062936X.2022.2120068","volume":"33","author":"P Kumar","year":"2022","unstructured":"Kumar P, Singh R, Kumar A, Toropova AP, Toropov AA, Devi M, Lal S, Sindhu J, Singh D. Identifications of good and bad structural fragments of hydrazone\/2,5-disubstituted-1,3,4-oxadiazole hybrids with correlation intensity index and consensus modelling using Monte Carlo based QSAR studies, their molecular docking and ADME analysis. SAR QSAR Environ Res. 2022;33:677\u2013700. https:\/\/doi.org\/10.1080\/1062936X.2022.2120068.","journal-title":"SAR QSAR Environ Res"},{"key":"3675_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4018\/IJQSPR.2016010102","volume":"1","author":"D Gadaleta","year":"2016","unstructured":"Gadaleta D, Mangiatordi GF, Catto M, Carotti A, Nicolotti O. Applicability domain for QSAR models: where theory meets reality. IJQSPR. 2016;1:45\u201363. https:\/\/doi.org\/10.4018\/IJQSPR.2016010102.","journal-title":"IJQSPR"},{"key":"3675_CR30","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/qsar.200610151","volume":"26","author":"P Gramatica","year":"2007","unstructured":"Gramatica P. Principles of QSAR models validation: internal and external. QSAR Comb Sci. 2007;26:694\u2013701. https:\/\/doi.org\/10.1002\/qsar.200610151.","journal-title":"QSAR Comb Sci"},{"key":"3675_CR31","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/1062936X.2023.2212175","volume":"34","author":"K Bagri","year":"2023","unstructured":"Bagri K, Kapoor A, Kumar P, Kumar A. Hybrid descriptors-conjoint indices: a case study on imidazole-thiourea containing glutaminyl cyclase inhibitors for design of novel anti-Alzheimer\u2019s candidates. SAR QSAR Environ Res. 2023;34:361\u201381. https:\/\/doi.org\/10.1080\/1062936X.2023.2212175.","journal-title":"SAR QSAR Environ Res"},{"key":"3675_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13065-023-00999-y","volume":"17","author":"F Tajiani","year":"2023","unstructured":"Tajiani F, Ahmadi S, Lotfi S, Kumar P, Almasirad A. In-silico activity prediction and docking studies of some flavonol derivatives as anti-prostate cancer agents based on Monte Carlo optimization. BMC Chem. 2023;17:87. https:\/\/doi.org\/10.1186\/s13065-023-00999-y.","journal-title":"BMC Chem"},{"key":"3675_CR33","doi-asserted-by":"publisher","first-page":"103893","DOI":"10.1016\/j.etap.2022.103893","volume":"93","author":"P Kumar","year":"2022","unstructured":"Kumar P, Kumar A, Singh D. CORAL: Development of a hybrid descriptor based QSTR model to predict the toxicity of dioxins and dioxin-like compounds with correlation intensity index and consensus modelling. Environ Toxicol Pharmacol. 2022;93:103893. https:\/\/doi.org\/10.1016\/j.etap.2022.103893.","journal-title":"Environ Toxicol Pharmacol"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-024-03675-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-024-03675-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-024-03675-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T17:07:42Z","timestamp":1710176862000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-024-03675-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["3675"],"URL":"https:\/\/doi.org\/10.1007\/s11095-024-03675-5","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,9]]},"assertion":[{"value":"1 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}